Autonomic dysregulations in parkinson's syndrome;Autonome regulationsstörungen beim parkinsonsyndrom

Praxis

Volumn 94, Issue 42, 2005, Pages 1639-1646

  Jost, W H ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Autonomic nervous system; Cardiovascular symptoms; Gastrointestinal symptoms; Idiopathic Parkinson's disease; Urogenital symptoms

Indexed keywords

EID: 80051664804     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.94.42.1639     Document Type: Review

References (44)

1. Jost WH. Autonome Regulationsstörungen beim Parkinson-Syndrom. Shaker-Verlag, Aachen 1999
2. Zesiewicz TA, Baker MJ, Wahba M, Hauser RA. Autonomic nervous system dysfunction in Parkinson's disease. Curr Treatm Opt Neurol 2003; 5: 149-60.
3. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Autonom Res 2005; 15: 76-82. (Pubitemid 40591296)
4. Mesec A, Sega S, Kiauta T. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic response. Clin Auton Res 1993; 3: 339-44. (Pubitemid 24171289)
5. Micieli G, Martignoni E, Cavallini A et al. Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 1987; 37: 386-93. (Pubitemid 17031732)
6. Turkka JT, Tolonen U, Myllylä VV. Cardiovascular reflexes in Parkinson's disease. Eur Neurol 1987; 26: 104-12. (Pubitemid 17232855)
7. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Autonom Res 2001; 11: 351-5. (Pubitemid 34461714)
8. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990; 53: 463-8.
9. Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1470-1. (Pubitemid 39279820)
10. Chaudhuri KR, Ellis C, Love-Jones S, et al. Postprandial hypotension and parkinsonian state in Parkinson's disease. Mov Disord 1997; 12: 877-84. (Pubitemid 27496763)
11. Braak H, Del Tredici K, Bratzke H et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease. J Neurol 2002; 249(3): 1-5.
12. Goldstein DS, Holmes CS, Dendi R, et al. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 2002; 58: 1247-55. (Pubitemid 34411870)
13. Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in Parkinson's disease J Neural Transm 2001; 108: 205-13. (Pubitemid 32695762)
14. Oppenheim H. Kleine Beiträge zur Neuropathologie. J Psychol Neurol 1902; 1: 129-146
15. Aminoff MJ, Wilcox CS. Assessment of autonomic function in patients with a Parkinsonian syndrome. Br Med J 1971; 4: 80-4.
16. Taly AB, Muthane UB. Involvement of peripheral nervous system in juvenile Parkinson's disease. Acta Neurol Scand 1992; 85: 272-5.
17. Martignoni E, Pacchetti C, Godi L, et al. Autonomic disorders in Parkinson's disease. J Neural Transm 1995; 45 Suppl.: 11-9.
18. Eadie MJ, Tyrer JH. Alimentary disorder in parkinsonism. Australas Ann Med 1965; 14: 13-22.
19. Edwards L, Quigley EMM, Hofman R, et al. Gastrointestinal symptoms in Parkinson Disease: 18-month follow-up study. Mov Disord 1993; 8: 83-6. (Pubitemid 23039236)
20. Parkinson J. An essay on the shaking palsy. Sherwood, Neely, and Jones, London 1817
21. Schwab RS, England AC. Parkinson's disease. J Chron Dis 1958; 8: 488-509.
22. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999; 14: 1057.
23. Lipp A, Trottenberg T, Schink T, et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003; 61: 1279-81. (Pubitemid 37377556)
24. Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson's Disease. Neurology 1989; 39: 1309-14. (Pubitemid 19246802)
25. Nowack WJ, Hatelid JM, Sohn RS. Dysphagia in parkinsonism. Arch Neurol 1977; 34: 320.
26. Ertekin C, Tarlaci S, Aydogdu I, et al. Electrophysiological evaluation of pharyngeal pahse of swallowing in patients with Parkinson's disease. Mov Disord 2002; 17: 942-9. (Pubitemid 36040999)
27. Palmer ED. Dysphagia in parkinsonism. JAMA 1974; 229: 1349.
28. Kurlan R, Rubin AJ, Miller C, et al. Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism. Ann Neurol 1985; 18: 139.
29. Champion MC. Domperidone. Gen Pharmac 1988; 19: 499-505.
30. Parkes JD. Domperidone and Parkinson's disease. Clin Neuropharmacol 1986; 9: 517-32. (Pubitemid 17217322)
31. Calne DB, Shaw DG, Spiers ASD, et al. Swallowing in parkinsonism. Br J Radiol 1979; 43: 456-7.
32. Mathers SE, Kempster PA, Law PJ, et al. Anal sphincter dysfunction in Parkinson's disease. Arch Neurol 1989; 46: 1061-4. (Pubitemid 19246293)
33. Ashraf W, Wszolek ZK, Pfeiffer RF, et al. Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 1995; 10:650-7.
34. Liu Z, Sakakibara R, Odaka T, et al. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients. Mov Disord 2005; 20: 680-6. (Pubitemid 41051779)
35. Eichhorn TE, Oertel WH. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multi system atrophy. Mov Disord 2001; 16: 1176-7. (Pubitemid 36041238)
36. Lewy FH. Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilk 1913; 50: 50-5.
37. Andersen JT, Hebjørn S, Frimodt-Møller C, et al. Disturbances of micturition in Parkinson's disease. Acta Neurol Scand 1976; 53:161-70.
38. Raz S. Parkinsonism and neurogenic bladder. Urol Res 1976; 4: 133-8.
39. Lemack GE, Dewey RB, Roehrborn CR, et al. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology 2000; 56: 250-4. (Pubitemid 30495577)
40. Winge K, Werdelin LM, Nielsen KK, Stimpel H. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodynam 2004; 23: 689-96. (Pubitemid 39313943)
41. Galloway NTM. Urethral sphincter abnormalities in parkinsonism. Br J Urol 1983; 55: 691-3. (Pubitemid 14208659)
42. Macht M, Schwarz R, Ellgring H. Psychosoziale Belastungen bei Parkinson-Patienten: ausgewählte Ergebnisse einer bundesweiten Befragung. Sexmed Arzt 1999; 2: 18-21.
43. Singer C, Weiner WJ, Sanchez-Ramos JR, et al. Sexual dysfunction in men with Parkinson's disease. J Neuro Rehab 1989; 3: 199-204.
44. Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 2000; 15: 305-8. (Pubitemid 30166738)